Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irrisept in emergency general surgery
NCT07048899Phase 4Enrolling by invitation
- Sponsor
- The University of Texas Health Science Center at Tyler
- Start
- Sep 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Irrisept in surgical site infection (SSI), sponsored by The University of Texas Health Science Center at Tyler. Started Sep 2024; status: enrolling by invitation.
02
Drugs
Irrisept
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07048899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07048899.